Autoimmunity and β cell regeneration in mouse and human type 1 diabetes -: The peace is not enough

被引：37

作者：

Ablamunits, Vitaly ^{[1
]}

Sherry, Nicole A. ^{[1
]}

Kushner, Jake A. ^{[1
]}

Herold, Kevan C. ^{[1
]}

机构：

[1] Yale Univ, Dept Med, Immunol Sect, New Haven, CT 06520 USA

来源：

HOW DO WE BEST EMPLOY ANIMAL MODELS FOR TYPE 1 DIABETES AND MULTIPLE SCLEROSIS? | 2007年 / 1103卷

关键词：

immune therapy; type; 1; diabetes; beta cell regeneration;

D O I：

10.1196/annals.1394.006

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Accumulating data from animal models of type 1 diabetes and some findings from clinical studies suggest that autoimmune destruction of islet beta cells is associated with enhanced beta cell regeneration. Successful immune therapies, aimed at preservation of islet cell mass, result in a remarkable reduction of beta cell regeneration. Treated or not, as long as the task of treatment is limited by "making peace" with antoimmunity, the process of beta cell loss continues. Additional therapeutic modalities capable of stimulating beta cell regeneration in the absence of active autoimmune destruction are urgently needed.

引用

页码：19 / 32

页数：14

共 47 条

[11] Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation [J].

Dor, Y ;

Brown, J ;

Martinez, OI ;

Melton, DA .

NATURE, 2004, 429 (6987) :41-46

[12]

DUSETTI NJ, 2005, BIOCHEM J, V307, P9

[13] DYNAMICS OF BETA-CELL MASS IN THE GROWING RAT PANCREAS - ESTIMATION WITH A SIMPLE MATHEMATICAL-MODEL [J].

FINEGOOD, DT ;

SCAGLIA, L ;

BONNERWEIR, S .

DIABETES, 1995, 44 (03) :249-256

[14] Direct lineage tracing reveals the ontogeny of pancreatic cell fates during mouse embryogenesis [J].

Gu, GQ ;

Brown, JR ;

Melton, DA .

MECHANISMS OF DEVELOPMENT, 2003, 120 (01) :35-43

[15]

Hebrok M, 2000, DEVELOPMENT, V127, P4905

[16] A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes [J].

Herold, KC ;

Gitelman, SE ;

Masharani, U ;

Hagopian, W ;

Bisikirska, B ;

Donaldson, D ;

Rother, K ;

Diamond, B ;

Harlan, DM ;

Bluestone, JA .

DIABETES, 2005, 54 (06) :1763-1769

[17] Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus [J].

Herold, KC ;

Hagopian, W ;

Auger, JA ;

Poumian-Ruiz, E ;

Taylor, L ;

Donaldson, D ;

Gitelman, SE ;

Harlan, DM ;

Xu, DL ;

Zivin, RA ;

Bluestone, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (22) :1692-1698

[18] In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion [J].

Ianus, A ;

Holz, GG ;

Theise, ND ;

Hussain, MA .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (06) :843-850

[19] Islet endothelial cells and pancreatic β-cell proliferation:: Studies in vitro and during pregnancy in adult rats [J].

Johansson, M ;

Mattsson, G ;

Andersson, A ;

Jansson, L ;

Carlsson, PO .

ENDOCRINOLOGY, 2006, 147 (05) :2315-2324

[20] Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes [J].

Keymeulen, B ;

Vandemeulebroucke, E ;

Ziegler, AG ;

Mathieu, C ;

Kaufman, L ;

Hale, G ;

Gorus, F ;

Goldman, M ;

Walter, M ;

Candon, S ;

Schandene, L ;

Crenier, L ;

De Block, C ;

Seigneurin, JM ;

De Pauw, P ;

Pierard, D ;

Weets, I ;

Rebello, P ;

Bird, P ;

Berrie, E ;

Frewin, M ;

Waldmann, H ;

Bach, JF ;

Pipeleers, D ;

Chatenoud, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (25) :2598-2608

← 1 2 3 4 5 →